Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZQ8Z
|
|||
Former ID |
DNC004795
|
|||
Drug Name |
7-Methoxy-2-morpholin-4-yl-chromen-4-one
|
|||
Synonyms |
CHEMBL175459; 130735-66-9; 4H-1-Benzopyran-4-one, 7-methoxy-2-(4-morpholinyl)-; 7-methoxy-2-morpholin-4-yl-chromen-4-one; ACMC-20mts5; 4H-1-Benzopyran-4-one,7-methoxy-2-(4-morpholinyl)-; SCHEMBL3536694; CTK0C1164; DTXSID00466243; BDBM50159634
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C14H15NO4
|
|||
Canonical SMILES |
COC1=CC2=C(C=C1)C(=O)C=C(O2)N3CCOCC3
|
|||
InChI |
1S/C14H15NO4/c1-17-10-2-3-11-12(16)9-14(19-13(11)8-10)15-4-6-18-7-5-15/h2-3,8-9H,4-7H2,1H3
|
|||
InChIKey |
TVHCBKPEOVWUEQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 130735-66-9
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | DNA-dependent protein kinase catalytic (PRKDC) | Target Info | Inhibitor | [1] |
KEGG Pathway | Non-homologous end-joining | |||
Cell cycle | ||||
NetPath Pathway | IL1 Signaling Pathway | |||
Pathway Interaction Database | DNA-PK pathway in nonhomologous end joining | |||
Coregulation of Androgen receptor activity | ||||
Class I PI3K signaling events mediated by Akt | ||||
BARD1 signaling events | ||||
Reactome | Nonhomologous End-Joining (NHEJ) | |||
WikiPathways | DNA Damage Response | |||
Non-homologous end joining | ||||
FAS pathway and Stress induction of HSP regulation | ||||
Cytosolic sensors of pathogen-associated DNA | ||||
Retinoblastoma (RB) in Cancer | ||||
Prostate Cancer | ||||
Double-Strand Break Repair | ||||
Cell Cycle | ||||
miRNA Regulation of DNA Damage Response |
References | Top | |||
---|---|---|---|---|
REF 1 | Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and... J Med Chem. 2005 Jan 27;48(2):569-85. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.